DRUG PRODUCTION AND ITS REGULATORY REQUIREMENTS: EXPANDING THE SCOPE OF PHARMACEUTICAL SAFETY AND INNOVATION

Аннотация

This expanded article delves deeply into the pharmaceutical manufacturing process, examining the global and national regulations, quality assurance mechanisms, clinical and post-marketing evaluations, and the environmental and ethical implications of drug production. It explores the growing role of digital innovations such as AI and bioinformatics in the sector and emphasizes Uzbekistan’s achievements and challenges. A comparative analysis of international best practices is also provided, aimed at informing policy reforms and fostering sustainable pharmaceutical development. Keywords: Pharmaceutical industry, GMP, GxP, AI in pharma, drug safety, pharmacovigilance, clinical trials, eco-pharma, regulatory harmonization, Uzbekistan healthcare.